IQVIA HOLDINGS INC. (IQV)

IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its solutions are powered by IQVIA Connected Intelligence, which combines high-quality health data, AI, advanced analytics, technology and domain expertise. The company holds one of the largest collections of healthcare information in the world, including more than 1.2 billion non-identified longitudinal patient records and about 68 petabytes of proprietary data from roughly 150,000 data suppliers. It provides information and insights on approximately 90% of the world's pharmaceuticals, measured by 2024 sales. It has about 93,000 employees in over 100 countries.

For 2025 the company reported three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions offers cloud-based SaaS platforms (CRM, performance management, compliance and safety reporting, multi-channel marketing and master data management), real world solutions, analytics and consulting, and information offerings such as national and sub-national sales and prescribing data and a database tracking over 22 million healthcare professionals. Research & Development Solutions covers project management and clinical monitoring for Phase I-IV trials, clinical trial support, central and specialty laboratory services, strategic planning and design, and patient and site-centric solutions, including the Avacare Clinical Research Network site management organization. Contract Sales & Medical Solutions provides healthcare provider engagement and contract sales, nurse-based patient engagement programs, and medical services. Effective January 1, 2026, the reportable segments became Commercial Solutions and Research & Development Solutions.

Life sciences companies, including pharmaceutical, biotechnology, device and diagnostic, and consumer health companies, account for the majority of revenues. Nearly all of the top 100 global pharmaceutical and biotechnology companies are clients. Other clients include payers, government and regulatory agencies, providers, pharmaceutical distributors and pharmacies. The company has over 10,000 clients in over 100 countries, and no single client reached 10% of revenues in 2023 through 2025; the largest contributed about 5% in 2025. IQVIA estimates its addressable market at about $335 billion, spanning outsourced research and development, real-world evidence and connected health, and technology-enabled commercial operations. Its growth strategy centers on innovating through Connected Intelligence, building on client relationships, expanding into the broader healthcare market, and making strategic acquisitions.

Operationally, IQVIA relies on a healthcare-specific global IT infrastructure that receives about 120 billion healthcare records a year and applies privacy, security and contractual protections, including internally developed tokenization engines. Its research segment includes a global laboratory network. The Technology & Analytics Solutions business competes with a broad and diverse set of businesses.